It’s been a busy week in the world of ETFs as we head into the earnings season.
Here’s a look at the Top 5 Most Viewed Articles on ETF Trends this week, April 4-8.
1. A Moneyball Approach to Deliver a Smarter ETF
Moneyball may have missed out on winning Best Picture at the Oscars a few years back, but the story of how Billy Beane changed baseball by using statistical analysis to predict tomorrow’s big winners is every numbers-geek’s dream. And it has more to do with the success of your clients’ portfolios than you might think. Read more >>
2. The Best and Worst ETFs of the First Quarter
The equities market and stock exchange traded funds just wrapped up an impressive recovery to what was one of the worst starts to a new year. While the stock markets gyrated and clawed back from the earlier plunge, there were some areas that shined through the muck. Read more >>
3. Silver Lining for Biotechnology ETFs After Pfizer Calls off Allergan Deal
Pfizer (NasdaqGS: PFE) called off the deal with Allergan (NasdaqGS: AGN) on Wednesday, but there was a silver lining. Exchange traded funds that track the biotechnology sector surged as traders speculated that the two companies could court other merger targets. Read more >>
4. ETF Strategies for an Earnings Recession
We have seen and heard a lot of discussion about the current “earnings recession” and it sounds like really bad news for the stock market. Depending on which measurement of S&P 500 earnings per share (EPS) is utilized, comparisons have been negative for the past two to four quarters as Q4 2015 EPS will finish around -3.6% year over year. This meets the common “recession” definition of two or more quarters of negative growth. Read more >>
5. Why This Dividend ETF Continues to Work
With the Federal Reserve standing pat on interest rate increases to this point in 2016, high dividend stocks and the related exchange traded funds have benefited in significant fashion. However, that does not change the fact that high yielders are vulnerable to higher interest rates. Read more >>